T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY
US Patent 12,558,424
Filed on 2022-02-07
Filed on 2022-02-07
Chimeric Antigen Receptors Targeting CD-19
Japan
2021-215427
Filed on 2021-12-29
2021-215427
Filed on 2021-12-29
CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19
US Application 17/557,845
Filed on 2021-12-21
Filed on 2021-12-21
ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS
Japan
2021-203953
Filed on 2021-12-16
2021-203953
Filed on 2021-12-16
Methods of Analyzing Virus-Derived Therapeutics
Macao
J/005746
Filed on 2022-01-19
J/005746
Filed on 2022-01-19
CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS AND A COSTIMULATORY SIGNAL PROTEIN USING A VLP-REPLICON
The Netherlands
20150087.3
Filed on 2014-12-16
20150087.3
Filed on 2014-12-16
CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS AND A COSTIMULATORY SIGNAL PROTEIN USING A VLP-REPLICON
Italy
20150087.3
Filed on 2014-12-16
20150087.3
Filed on 2014-12-16
CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS AND A COSTIMULATORY SIGNAL PROTEIN USING A VLP-REPLICON
Ireland
20150087.3
Filed on 2014-12-16
20150087.3
Filed on 2014-12-16
CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS AND A COSTIMULATORY SIGNAL PROTEIN USING A VLP-REPLICON
United Kingdom
20150087.3
Filed on 2014-12-16
20150087.3
Filed on 2014-12-16